阿巴洛帕肽促进拔牙窝种植体缺损骨再生的体内实验研究
本研究在大鼠模型上评估全身给予阿巴洛帕肽(ABL)对拔牙窝愈合及种植体骨结合的影响。结果显示ABL增加42天拔牙窝再生骨的骨体积分数(p=0.004)和骨密度(p=0.006),并加速种植体周围早期骨形成。
要点
- ABL增加42天拔牙窝骨体积分数(p=0.004)和骨密度(p=0.006)。
- ABL组42天拔牙窝矿化骨面积高于对照组(p=0.03)。
- ABL组种植后21天种植体周围再生骨矿化骨面积高于对照组(p=0.01)。
核心结论
- 在大鼠模型中,全身给予ABL增强种植前拔牙窝的骨生成,并加速愈合早期种植体周围骨形成。
研究设计与样本
- 临床前啮齿动物体内实验:Sprague-Dawley大鼠在maxillary first molar(M1)拔牙手术时每日皮下注射ABL(25 μg/kg)或赋形剂(VEH)。
主要发现
- Micro-CT显示ABL增加42天再生拔牙窝的骨体积分数(p=0.004)和骨密度(p=0.006)。
- Micro-CT显示股骨松质骨密度在治疗6周(p<0.01)、9周(p<0.001)和14周(p<0.001)时ABL组更高,验证全身效应。
- Histomorphometry证实42天拔牙窝矿化骨面积ABL组高于对照组(p=0.03)。
- Histomorphometry证实在种植体植入后21天种植体周围再生骨矿化骨面积ABL组高于对照组(p=0.01)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Abaloparatide (ABL) is a synthetic parathyroid hormone-related protein analog developed as an anabolic drug to treat osteoporosis. ABL increases bone mineral density (BMD) of the long bones and spine; however, the influence of ABL on alveolar bone regeneration remains unknown. This study assessed the effects of systemic ABL administration on tooth extraction socket healing and dental implant osseointegration in a preclinical rodent model. METHODS: Sprague-Dawley rats received daily subcutaneous injection of ABL (25 μg/kg) or vehicle (VEH) at the time of maxillary first molar (M1) extraction surgery; animals underwent either: (1) unilateral M1 extraction followed by sacrifice at 10 or 42d or (2) bilateral M1 extraction followed by staged implant placement in osteotomies with standardized defects and sacrifice at 21 or 28d. RESULTS: Micro-computed tomography (micro-CT) analysis demonstrated that ABL increased bone volume fraction (p = 0.004) and bone mineral density (BMD) (p = 0.006) of regenerated extraction sockets at 42d. Micro-CT of the femur validated systemic effects of ABL, showing greater trabecular BMD after 6 (p < 0.01), 9 (p < 0.001), and 14 (p < 0.001) weeks of treatment. Histomorphometry confirmed a higher mineralized bone area with ABL treatment in extraction sockets at 42d (p = 0.03) and in the regenerated peri-implant bone at 21d post-implant placement (p = 0.01) compared to control. CONCLUSION: Systemic ABL administration enhances osteogenesis in extraction sockets prior to implant placement and accelerates peri-implant bone formation in the early phase of healing in the present rodent model.
引用
- Latimer J, Yilmaz B, Feher B, et al. Abaloparatide Enhances Bone Regeneration in Extraction Socket Dental Implant Defects: An Experimental In Vivo Study. Clin Oral Implants Res. 2025. PMID: 39789749. doi:10.1111/clr.14397
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。